Sunday, October 24, 2021
Coronavirus
Data Center
Economic Activity
Education
Financial Services
Food & Agriculture
Government
Health Services
Manufacturing
Nonprofit
Real Estate
Technology

TOPICS

Home Tags Dr. Pablo J. Cagnoni

Tag: Dr. Pablo J. Cagnoni

Rubius Therapeutics posts $42.3M loss in Q1

Health Services
CAMBRIDGE, Mass. – Rubius Therapeutics Inc. reported a $42.3 million loss in the first quarter of 2021, or 51 cents per diluted share, the...
RUBIUS THERAPEUTICS ended 2020 with a loss of $167.7 million.

Rubius Therapeutics reports $167.7M loss in 2020

Health Services
CAMBRIDGE, Mass. – Rubius Therapeutics Inc. reported Tuesday a loss of $167.7 million in 2020, or $2.08 per diluted share. The clinical-stage biopharmaceutical company, which...

Rubius announces 3 new patents for cellular-therapy program

Manufacturing
PROVIDENCE – Rubius Therapeutics, a Cambridge, Mass.-based biotech firm that develops and genetically engineers red blood cells for use in medications for rare diseases,...

Rubius appoints Holles to board, Whitehead as SVP, chief quality officer

Health Services
PROVIDENCE – Rubius Therapeutics Inc. has appointed Natalie Holles to its board of directors and Greg Whitehead as senior vice president and chief quality...

Stay up to date with PBN's Morning Call & Daily Edition newsletters.

By submitting your information you are agreeing to our Privacy Policy and Terms of Use

- Featured Event -

Latest News

SUBSCRIBE TO

PBN's All Access Subscription

PBN subscribers get ahead with unlimited access to PBN news, information, and insights from our editorial team, research and data, webinars and much more.

Subscribe

SIGN UP FOR

PBN's Daily Newsletter

Get PBN's top stories every morning in your email inbox.

FOLLOW US

@ProvBusNews

Follow PBN for the latest news, insider access and more.

MOST POPULAR

OUR MISSION

To be the trusted business news and information source for the Rhode Island and Southeastern MA business community providing timely, insightful, in-depth and breaking news coverage that advances individual and company growth and success in local, state and global markets.

ABOUT PBN

© Providence Business News. All Rights Reserved.

Privacy   |   Terms of Use

Register to read all articles free - This week only!

CLOSE

One week only, get full access to all articles on PBN.com when you create a complimentary account.

One week only, get full access to all articles on PBN.com when you create a complimentary account.

 

Register today >>

Sign-up to get the

PBN Daily Edition

A collection of all the published news of the last 24 hours, as well as selected features from PBN’s weekly print edition.

By submitting the form you agree to PBN's Privacy Policy and Terms of Use.

Unfortunately, you have run out of free stories. Fortunately, if you register now you can keep reading with limited access or for unlimited access subscribe for $4 for 4 weeks.

We’re glad you are enjoying PBN.